AllQuantitative Report
logoArgusJanuary 13, 2021

NEO: Raising target price to $57.00

Symbols
NEO
Sector(s)
Healthcare
Rating
Current Price
$15.72
Price Target
Earnings Estimate
Summary

NeoGenomics Inc operates a network of cancer-focused genetic testing laboratories in the United States as well as a laboratory in Switzerland.

Subscribe to Yahoo Finance Plus Essential for full access
Exclusive reports, detailed company profiles, and best-in-class trade insights to take your portfolio to the next level